Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3645852 | 0.97 | TAAR1 (0.62) | TAAR1 | |
| SCHEMBL3683667 | 0.93 | TAAR1 (0.58) | TAAR1 | |
| SCHEMBL3642495 | 0.90 | TAAR1 (0.79) | TAAR1S1PR1 | |
| SCHEMBL3645668 | 0.90 | TAAR1 (0.79) | TAAR1S1PR1 | |
| SCHEMBL4247984 | 0.89 | TAAR1 (0.80) | TAAR1 | |
| SCHEMBL3645506 | 0.88 | TAAR1 (0.77) | TAAR1 | |
| SCHEMBL3641066 | 0.87 | TAAR1 (0.70) | TAAR1 | |
| SCHEMBL3645068 | 0.85 | TAAR1 (0.65) | TAAR1 | |
| SCHEMBL3679927 | 0.82 | TAAR1 (0.72) | TAAR1 | |
| SCHEMBL4254287 | 0.82 | TAAR1 (0.68) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2182935-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. Hoffmann-Roche AG (CH) | 2010-05-12 | — | — | EP | claimed |
| WO-2009016088-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | WO | claimed |
| EP-2182935-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. Hoffmann-Roche AG (CH) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009016088-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | WO | disclosed |